Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
Hasta un tercio de los reemplazos de rodilla causan dolor… y arrepentimiento
Los 723,000 reemplazos de rodilla realizados en 2014 costaron a pacientes, aseguradoras y contribuyentes más de $40.000 millones. No siempre funcionan.
Up To A Third Of Knee Replacements Pack Pain And Regret
Many patients face lingering pain and disappointment after undergoing knee replacement surgery, which costs an average $31,000. And doctors are increasingly concerned that the procedure is overused and that its benefits have been oversold.
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
Píldoras de aceite de pescado y de vitamina D no protegen contra el cáncer o males cardíacos
Los investigadores definieron los males cardíacos graves como el índice combinado de ataques cardíacos, apoplejía y muertes relacionadas con el corazón.
Soda Industry Steals Page From Tobacco To Combat Taxes On Sugary Drinks
Voters in Oregon, Washington will decide whether to strip cities of ability to tax sugary drinks.
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
La “medicina de precisión” para combatir el cáncer no siempre logra su objetivo
Estas terapias focalizadas, que ajustan la medicina a la genética de la enfermedad, no tienen el éxito que los médicos, y el público en general, esperan.
Much Touted For Cancer, ‘Precision Medicine’ Often Misses The Target
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
For Nursing Home Patients, Breast Cancer Surgery May Do More Harm Than Good
A new study of 6,000 older patients shows little gain from surgeries for breast cancer.
